{"entity":{"type":"insider","cik":"0001388325","url":"/insider/0001388325","json_url":"/insider/0001388325.json","name":"Novo Holdings A/S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":724,"n_filings":135,"first":"2007-02-02","last":"2026-05-05","span_basis":"filed_date"},"name_variants":[{"name":"Novo Holdings A/S","source":"filing","n_filings":66,"first_seen":"2017-06-27","last_seen":"2026-05-05"},{"name":"Novo A/S","source":"filing","n_filings":69,"first_seen":"2007-02-02","last_seen":"2017-06-14"}],"transactions":[{"id":6205655,"accession":"0001388325-26-000021","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001388325-26-000021","line_url":"/filing/0001388325-26-000021#line-2","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Avalyn Pharma Inc.","issuer_ticker":"AVLN","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Voting Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":555555.0,"shares_display":"555,555","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":9999990.0,"total_display":"9,999,990.00","total_whole":"9,999,990","shares_owned_after":3883289.0,"shares_owned_after_display":"3,883,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-01","filed_date":"2026-05-05","scope":"insider"},{"id":4073952,"accession":"0001388325-25-000018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001388325-25-000018","line_url":"/filing/0001388325-25-000018#line-2","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"MapLight Therapeutics, Inc.","issuer_ticker":"MPLT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Voting Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":952941.0,"shares_display":"952,941","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":16199997.0,"total_display":"16,199,997.00","total_whole":"16,199,997","shares_owned_after":3686622.0,"shares_owned_after_display":"3,686,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-28","filed_date":"2025-10-30","scope":"insider"},{"id":2545231,"accession":"0000950170-24-087061","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-087061","line_url":"/filing/0000950170-24-087061#line-2","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"IO Biotech, Inc.","issuer_ticker":"IOBT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23478.0,"shares_display":"23,478","price_per_share":1.3113,"price_display":"1.31","price_state":"stated","total_value":30786.7014,"total_display":"30,786.70","total_whole":"30,787","shares_owned_after":4354449.0,"shares_owned_after_display":"4,354,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-26","filed_date":"2024-07-26","scope":"insider"},{"id":2545227,"accession":"0000950170-24-087061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-087061","line_url":"/filing/0000950170-24-087061#line-1","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"IO Biotech, Inc.","issuer_ticker":"IOBT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51522.0,"shares_display":"51,522","price_per_share":1.3264,"price_display":"1.33","price_state":"stated","total_value":68338.7808,"total_display":"68,338.78","total_whole":"68,339","shares_owned_after":4377927.0,"shares_owned_after_display":"4,377,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-25","filed_date":"2024-07-26","scope":"insider"},{"id":2081657,"accession":"0000950170-24-059965","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-059965","line_url":"/filing/0000950170-24-059965#line-1","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"IO Biotech, Inc.","issuer_ticker":"IOBT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":658809.0,"shares_display":"658,809","price_per_share":1.2181,"price_display":"1.22","price_state":"stated","total_value":802495.2429,"total_display":"802,495.24","total_whole":"802,495","shares_owned_after":4429449.0,"shares_owned_after_display":"4,429,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-10","filed_date":"2024-05-14","scope":"insider"},{"id":2213855,"accession":"0001209191-24-005075","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-005075","line_url":"/filing/0001209191-24-005075#line-1","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"SPRUCE BIOSCIENCES, INC.","issuer_ticker":"SPRB","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":465021.0,"shares_display":"465,021","price_per_share":0.7547,"price_display":"0.75","price_state":"stated","total_value":350951.3487,"total_display":"350,951.35","total_whole":"350,951","shares_owned_after":2550000.0,"shares_owned_after_display":"2,550,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-21","filed_date":"2024-03-25","scope":"insider"},{"id":2435861,"accession":"0001209191-24-005017","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-24-005017","line_url":"/filing/0001209191-24-005017#line-3","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"SPRUCE BIOSCIENCES, INC.","issuer_ticker":"SPRB","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":359979.0,"shares_display":"359,979","price_per_share":0.7336,"price_display":"0.73","price_state":"stated","total_value":264080.5944,"total_display":"264,080.59","total_whole":"264,081","shares_owned_after":3015021.0,"shares_owned_after_display":"3,015,021","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-20","filed_date":"2024-03-20","scope":"insider"},{"id":2435854,"accession":"0001209191-24-005017","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-005017","line_url":"/filing/0001209191-24-005017#line-2","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"SPRUCE BIOSCIENCES, INC.","issuer_ticker":"SPRB","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":593000.0,"shares_display":"593,000","price_per_share":0.755,"price_display":"0.76","price_state":"stated","total_value":447715.0,"total_display":"447,715.00","total_whole":"447,715","shares_owned_after":3375000.0,"shares_owned_after_display":"3,375,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-19","filed_date":"2024-03-20","scope":"insider"},{"id":2435847,"accession":"0001209191-24-005017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-005017","line_url":"/filing/0001209191-24-005017#line-1","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"SPRUCE BIOSCIENCES, INC.","issuer_ticker":"SPRB","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":842020.0,"shares_display":"842,020","price_per_share":0.7684,"price_display":"0.77","price_state":"stated","total_value":647008.168,"total_display":"647,008.17","total_whole":"647,008","shares_owned_after":3968000.0,"shares_owned_after_display":"3,968,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-18","filed_date":"2024-03-20","scope":"insider"},{"id":2473244,"accession":"0001209191-24-004900","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-004900","line_url":"/filing/0001209191-24-004900#line-1","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"SPRUCE BIOSCIENCES, INC.","issuer_ticker":"SPRB","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1912316.0,"shares_display":"1,912,316","price_per_share":0.8884,"price_display":"0.89","price_state":"stated","total_value":1698901.5344,"total_display":"1,698,901.53","total_whole":"1,698,902","shares_owned_after":4810020.0,"shares_owned_after_display":"4,810,020","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-18","scope":"insider"},{"id":2037829,"accession":"0001209191-24-003423","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-24-003423","line_url":"/filing/0001209191-24-003423#line-3","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Metagenomi, Inc.","issuer_ticker":"MGX","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800000.0,"shares_display":"800,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":12000000.0,"total_display":"12,000,000.00","total_whole":"12,000,000","shares_owned_after":1739175.0,"shares_owned_after_display":"1,739,175","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-13","filed_date":"2024-02-15","scope":"insider"},{"id":3132127,"accession":"0001209191-24-003303","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-003303","line_url":"/filing/0001209191-24-003303#line-1","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"IO Biotech, Inc.","issuer_ticker":"IOBT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":658809.0,"shares_display":"658,809","price_per_share":1.5003,"price_display":"1.50","price_state":"stated","total_value":988411.1427,"total_display":"988,411.14","total_whole":"988,411","shares_owned_after":5088258.0,"shares_owned_after_display":"5,088,258","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-09","filed_date":"2024-02-13","scope":"insider"},{"id":2037827,"accession":"0001209191-24-003423","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-003423","line_url":"/filing/0001209191-24-003423#line-1","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Metagenomi, Inc.","issuer_ticker":"MGX","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":10.25,"price_display":"10.25","price_state":"stated","total_value":1025000.0,"total_display":"1,025,000.00","total_whole":"1,025,000","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-09","filed_date":"2024-02-15","scope":"insider"},{"id":8501283,"accession":"0001209191-23-045444","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-045444","line_url":"/filing/0001209191-23-045444#line-1","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"IO Biotech, Inc.","issuer_ticker":"IOBT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2469135.0,"shares_display":"2,469,135","price_per_share":2.025,"price_display":"2.02","price_state":"stated","total_value":4999998.375,"total_display":"4,999,998.38","total_whole":"4,999,998","shares_owned_after":5707467.0,"shares_owned_after_display":"5,707,467","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-09","filed_date":"2023-08-11","scope":"insider"},{"id":8752765,"accession":"0001209191-23-042977","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-042977","line_url":"/filing/0001209191-23-042977#line-2","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":2.7514,"price_display":"2.75","price_state":"stated","total_value":275140.0,"total_display":"275,140.00","total_whole":"275,140","shares_owned_after":3522136.0,"shares_owned_after_display":"3,522,136","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-20","filed_date":"2023-07-20","scope":"insider"},{"id":8752762,"accession":"0001209191-23-042977","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-042977","line_url":"/filing/0001209191-23-042977#line-1","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":2.7616,"price_display":"2.76","price_state":"stated","total_value":5247.04,"total_display":"5,247.04","total_whole":"5,247","shares_owned_after":3622136.0,"shares_owned_after_display":"3,622,136","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-19","filed_date":"2023-07-20","scope":"insider"},{"id":8254544,"accession":"0001209191-23-042670","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-042670","line_url":"/filing/0001209191-23-042670#line-3","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":2.7574,"price_display":"2.76","price_state":"stated","total_value":17923.1,"total_display":"17,923.10","total_whole":"17,923","shares_owned_after":3624036.0,"shares_owned_after_display":"3,624,036","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-18","filed_date":"2023-07-18","scope":"insider"},{"id":8254537,"accession":"0001209191-23-042670","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-042670","line_url":"/filing/0001209191-23-042670#line-2","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21100.0,"shares_display":"21,100","price_per_share":2.7488,"price_display":"2.75","price_state":"stated","total_value":57999.68,"total_display":"57,999.68","total_whole":"58,000","shares_owned_after":3630536.0,"shares_owned_after_display":"3,630,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-17","filed_date":"2023-07-18","scope":"insider"},{"id":8254534,"accession":"0001209191-23-042670","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-042670","line_url":"/filing/0001209191-23-042670#line-1","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":2.7365,"price_display":"2.74","price_state":"stated","total_value":30101.5,"total_display":"30,101.50","total_whole":"30,102","shares_owned_after":3651636.0,"shares_owned_after_display":"3,651,636","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-14","filed_date":"2023-07-18","scope":"insider"},{"id":8629539,"accession":"0001209191-23-040691","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-040691","line_url":"/filing/0001209191-23-040691#line-1","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200937.0,"shares_display":"200,937","price_per_share":2.6341,"price_display":"2.63","price_state":"stated","total_value":529288.1517,"total_display":"529,288.15","total_whole":"529,288","shares_owned_after":3662636.0,"shares_owned_after_display":"3,662,636","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-30","filed_date":"2023-07-03","scope":"insider"},{"id":8752598,"accession":"0001209191-23-040057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-040057","line_url":"/filing/0001209191-23-040057#line-1","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250000.0,"shares_display":"1,250,000","price_per_share":46.1,"price_display":"46.10","price_state":"stated","total_value":57625000.0,"total_display":"57,625,000.00","total_whole":"57,625,000","shares_owned_after":1090772.0,"shares_owned_after_display":"1,090,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-28","filed_date":"2023-06-28","scope":"insider"},{"id":8469735,"accession":"0001209191-23-040129","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-040129","line_url":"/filing/0001209191-23-040129#line-2","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31978.0,"shares_display":"31,978","price_per_share":1.7727,"price_display":"1.77","price_state":"stated","total_value":56687.4006,"total_display":"56,687.40","total_whole":"56,687","shares_owned_after":3863573.0,"shares_owned_after_display":"3,863,573","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-27","filed_date":"2023-06-28","scope":"insider"},{"id":8469730,"accession":"0001209191-23-040129","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-040129","line_url":"/filing/0001209191-23-040129#line-1","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8437.0,"shares_display":"8,437","price_per_share":1.7905,"price_display":"1.79","price_state":"stated","total_value":15106.4485,"total_display":"15,106.45","total_whole":"15,106","shares_owned_after":3895551.0,"shares_owned_after_display":"3,895,551","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-26","filed_date":"2023-06-28","scope":"insider"},{"id":8680116,"accession":"0001209191-23-039545","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-039545","line_url":"/filing/0001209191-23-039545#line-3","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3423.0,"shares_display":"3,423","price_per_share":1.8834,"price_display":"1.88","price_state":"stated","total_value":6446.8782,"total_display":"6,446.88","total_whole":"6,447","shares_owned_after":3903988.0,"shares_owned_after_display":"3,903,988","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-23","filed_date":"2023-06-23","scope":"insider"},{"id":8680108,"accession":"0001209191-23-039541","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-039541","line_url":"/filing/0001209191-23-039541#line-1","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Reneo Pharmaceuticals, Inc.","issuer_ticker":"RPHM","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":7.0974,"price_display":"7.10","price_state":"stated","total_value":709740.0,"total_display":"709,740.00","total_whole":"709,740","shares_owned_after":3330337.0,"shares_owned_after_display":"3,330,337","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-23","filed_date":"2023-06-23","scope":"insider"},{"id":8680114,"accession":"0001209191-23-039545","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-039545","line_url":"/filing/0001209191-23-039545#line-2","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5041.0,"shares_display":"5,041","price_per_share":1.9406,"price_display":"1.94","price_state":"stated","total_value":9782.5646,"total_display":"9,782.56","total_whole":"9,783","shares_owned_after":3907411.0,"shares_owned_after_display":"3,907,411","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-22","filed_date":"2023-06-23","scope":"insider"},{"id":8680111,"accession":"0001209191-23-039545","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-039545","line_url":"/filing/0001209191-23-039545#line-1","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4834.0,"shares_display":"4,834","price_per_share":1.9944,"price_display":"1.99","price_state":"stated","total_value":9640.9296,"total_display":"9,640.93","total_whole":"9,641","shares_owned_after":3912452.0,"shares_owned_after_display":"3,912,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-21","filed_date":"2023-06-23","scope":"insider"},{"id":8545832,"accession":"0001209191-23-038567","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-038567","line_url":"/filing/0001209191-23-038567#line-3","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":744.0,"shares_display":"744","price_per_share":2.1145,"price_display":"2.11","price_state":"stated","total_value":1573.188,"total_display":"1,573.19","total_whole":"1,573","shares_owned_after":3917286.0,"shares_owned_after_display":"3,917,286","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-20","filed_date":"2023-06-20","scope":"insider"},{"id":8545828,"accession":"0001209191-23-038567","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-038567","line_url":"/filing/0001209191-23-038567#line-2","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5983.0,"shares_display":"5,983","price_per_share":2.0294,"price_display":"2.03","price_state":"stated","total_value":12141.9002,"total_display":"12,141.90","total_whole":"12,142","shares_owned_after":3918030.0,"shares_owned_after_display":"3,918,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-16","filed_date":"2023-06-20","scope":"insider"},{"id":8545824,"accession":"0001209191-23-038567","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-038567","line_url":"/filing/0001209191-23-038567#line-1","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10002.0,"shares_display":"10,002","price_per_share":2.03,"price_display":"2.03","price_state":"stated","total_value":20304.06,"total_display":"20,304.06","total_whole":"20,304","shares_owned_after":3924013.0,"shares_owned_after_display":"3,924,013","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-15","filed_date":"2023-06-20","scope":"insider"},{"id":7815520,"accession":"0001209191-23-037208","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-037208","line_url":"/filing/0001209191-23-037208#line-3","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2872.0,"shares_display":"2,872","price_per_share":2.1066,"price_display":"2.11","price_state":"stated","total_value":6050.1552,"total_display":"6,050.16","total_whole":"6,050","shares_owned_after":3934015.0,"shares_owned_after_display":"3,934,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-14","filed_date":"2023-06-14","scope":"insider"},{"id":7815518,"accession":"0001209191-23-037208","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-037208","line_url":"/filing/0001209191-23-037208#line-2","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2626.0,"shares_display":"2,626","price_per_share":2.1,"price_display":"2.10","price_state":"stated","total_value":5514.6,"total_display":"5,514.60","total_whole":"5,515","shares_owned_after":3936887.0,"shares_owned_after_display":"3,936,887","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-13","filed_date":"2023-06-14","scope":"insider"},{"id":7815516,"accession":"0001209191-23-037208","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-037208","line_url":"/filing/0001209191-23-037208#line-1","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":2.0645,"price_display":"2.06","price_state":"stated","total_value":1858.05,"total_display":"1,858.05","total_whole":"1,858","shares_owned_after":3939513.0,"shares_owned_after_display":"3,939,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-12","filed_date":"2023-06-14","scope":"insider"},{"id":8325689,"accession":"0001209191-23-011156","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-011156","line_url":"/filing/0001209191-23-011156#line-1","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"SPRUCE BIOSCIENCES, INC.","issuer_ticker":"SPRB","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2208000.0,"shares_display":"2,208,000","price_per_share":3.17,"price_display":"3.17","price_state":"stated","total_value":6999360.0,"total_display":"6,999,360.00","total_whole":"6,999,360","shares_owned_after":6722336.0,"shares_owned_after_display":"6,722,336","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-16","filed_date":"2023-02-21","scope":"insider"},{"id":6574427,"accession":"0001209191-22-050258","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-050258","line_url":"/filing/0001209191-22-050258#line-1","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":484496.0,"shares_display":"484,496","price_per_share":10.32,"price_display":"10.32","price_state":"stated","total_value":4999998.72,"total_display":"4,999,998.72","total_whole":"4,999,999","shares_owned_after":6071703.0,"shares_owned_after_display":"6,071,703","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-14","filed_date":"2022-09-16","scope":"insider"},{"id":6925767,"accession":"0001209191-22-043049","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-043049","line_url":"/filing/0001209191-22-043049#line-1","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900000.0,"shares_display":"900,000","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":2700000.0,"total_display":"2,700,000.00","total_whole":"2,700,000","shares_owned_after":3940413.0,"shares_owned_after_display":"3,940,413","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-20","filed_date":"2022-07-22","scope":"insider"},{"id":6497100,"accession":"0001209191-22-042241","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-042241","line_url":"/filing/0001209191-22-042241#line-1","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800000.0,"shares_display":"800,000","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":1600000.0,"total_display":"1,600,000.00","total_whole":"1,600,000","shares_owned_after":3703991.0,"shares_owned_after_display":"3,703,991","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-13","filed_date":"2022-07-15","scope":"insider"},{"id":6693608,"accession":"0001209191-22-013316","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-013316","line_url":"/filing/0001209191-22-013316#line-3","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Checkmate Pharmaceuticals, Inc.","issuer_ticker":"CMPI","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":2.7032,"price_display":"2.70","price_state":"stated","total_value":810.96,"total_display":"810.96","total_whole":"811","shares_owned_after":2161990.0,"shares_owned_after_display":"2,161,990","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-25","filed_date":"2022-02-25","scope":"insider"},{"id":6693606,"accession":"0001209191-22-013316","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-013316","line_url":"/filing/0001209191-22-013316#line-2","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Checkmate Pharmaceuticals, Inc.","issuer_ticker":"CMPI","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5990.0,"shares_display":"5,990","price_per_share":2.8345,"price_display":"2.83","price_state":"stated","total_value":16978.655,"total_display":"16,978.66","total_whole":"16,979","shares_owned_after":2162290.0,"shares_owned_after_display":"2,162,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-24","filed_date":"2022-02-25","scope":"insider"},{"id":6693603,"accession":"0001209191-22-013316","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-013316","line_url":"/filing/0001209191-22-013316#line-1","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Checkmate Pharmaceuticals, Inc.","issuer_ticker":"CMPI","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1820.0,"shares_display":"1,820","price_per_share":2.8997,"price_display":"2.90","price_state":"stated","total_value":5277.454,"total_display":"5,277.45","total_whole":"5,277","shares_owned_after":2168280.0,"shares_owned_after_display":"2,168,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-23","filed_date":"2022-02-25","scope":"insider"},{"id":6651450,"accession":"0001209191-22-008145","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-008145","line_url":"/filing/0001209191-22-008145#line-2","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Arcellx, Inc.","issuer_ticker":"ACLX","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":833333.0,"shares_display":"833,333","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":12499995.0,"total_display":"12,499,995.00","total_whole":"12,499,995","shares_owned_after":4016878.0,"shares_owned_after_display":"4,016,878","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-08","filed_date":"2022-02-09","scope":"insider"},{"id":5500854,"accession":"0001209191-21-063969","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-063969","line_url":"/filing/0001209191-21-063969#line-2","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"IO Biotech, Inc.","issuer_ticker":"IOBT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":325000.0,"shares_display":"325,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":4550000.0,"total_display":"4,550,000.00","total_whole":"4,550,000","shares_owned_after":3277932.0,"shares_owned_after_display":"3,277,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-09","filed_date":"2021-11-10","scope":"insider"},{"id":5171815,"accession":"0001209191-21-061795","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-061795","line_url":"/filing/0001209191-21-061795#line-3","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"MINERVA SURGICAL INC","issuer_ticker":"UTRS","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":580000.0,"shares_display":"580,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":6960000.0,"total_display":"6,960,000.00","total_whole":"6,960,000","shares_owned_after":2057132.0,"shares_owned_after_display":"2,057,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-26","filed_date":"2021-10-27","scope":"insider"},{"id":4181457,"accession":"0001209191-21-042786","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-042786","line_url":"/filing/0001209191-21-042786#line-2","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Cyteir Therapeutics, Inc.","issuer_ticker":"CYT","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":277777.0,"shares_display":"277,777","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":4999986.0,"total_display":"4,999,986.00","total_whole":"4,999,986","shares_owned_after":4840413.0,"shares_owned_after_display":"4,840,413","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-22","filed_date":"2021-06-23","scope":"insider"},{"id":4274638,"accession":"0001209191-21-042452","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-042452","line_url":"/filing/0001209191-21-042452#line-2","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":350000.0,"shares_display":"350,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":6650000.0,"total_display":"6,650,000.00","total_whole":"6,650,000","shares_owned_after":793265.0,"shares_owned_after_display":"793,265","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-21","filed_date":"2021-06-22","scope":"insider"},{"id":4180829,"accession":"0001209191-21-037932","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-037932","line_url":"/filing/0001209191-21-037932#line-1","is_derivative":false,"issuer_cik":"0001294133","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001294133","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":680000.0,"shares_display":"680,000","price_per_share":57.32,"price_display":"57.32","price_state":"stated","total_value":38977600.0,"total_display":"38,977,600.00","total_whole":"38,977,600","shares_owned_after":2079320.0,"shares_owned_after_display":"2,079,320","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-02","filed_date":"2021-06-03","scope":"insider"},{"id":4338399,"accession":"0001209191-21-034923","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-034923","line_url":"/filing/0001209191-21-034923#line-1","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"SPRUCE BIOSCIENCES, INC.","issuer_ticker":"SPRB","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":475000.0,"shares_display":"475,000","price_per_share":13.9,"price_display":"13.90","price_state":"stated","total_value":6602500.0,"total_display":"6,602,500.00","total_whole":"6,602,500","shares_owned_after":4514336.0,"shares_owned_after_display":"4,514,336","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-19","filed_date":"2021-05-21","scope":"insider"},{"id":4825006,"accession":"0001209191-21-026667","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-026667","line_url":"/filing/0001209191-21-026667#line-2","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Reneo Pharmaceuticals, Inc.","issuer_ticker":"RPHM","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":666666.0,"shares_display":"666,666","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":9999990.0,"total_display":"9,999,990.00","total_whole":"9,999,990","shares_owned_after":3430377.0,"shares_owned_after_display":"3,430,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-13","filed_date":"2021-04-14","scope":"insider"},{"id":4476596,"accession":"0001209191-21-023779","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-023779","line_url":"/filing/0001209191-21-023779#line-2","is_derivative":false,"issuer_cik":"0001388325","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001388325","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":625000.0,"shares_display":"625,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","total_whole":"10,000,000","shares_owned_after":5587207.0,"shares_owned_after_display":"5,587,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-30","filed_date":"2021-03-31","scope":"insider"},{"id":5489388,"accession":"0001209191-21-016876","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-016876","line_url":"/filing/0001209191-21-016876#line-1","is_derivative":false,"issuer_cik":"0001294133","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001294133","owner_cik":"0001388325","owner_name":"Novo Holdings A/S","owner_display_name":"Novo Holdings A/S","owner_url":"/insider/0001388325","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":790000.0,"shares_display":"790,000","price_per_share":49.0,"price_display":"49.00","price_state":"stated","total_value":38710000.0,"total_display":"38,710,000.00","total_whole":"38,710,000","shares_owned_after":2759320.0,"shares_owned_after_display":"2,759,320","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"}],"collapsed":true,"next_cursor":"2021-03-01|5489388","ledger_fault":false,"count":{"value":724,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":609,"open_market":true},{"code":"S","label":"Open-market sale","n":115,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":724},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001540171","name":"Avalyn Pharma Inc.","url":"/issuer/0001540171","role":"Ten percent owner","n_filings":1,"first_seen":"2026-05-05","last_seen":"2026-05-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001770069","name":"MapLight Therapeutics, Inc.","url":"/issuer/0001770069","role":"Ten percent owner","n_filings":1,"first_seen":"2025-10-30","last_seen":"2025-10-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001865494","name":"IO Biotech, Inc.","url":"/issuer/0001865494","role":"Ten percent owner","n_filings":5,"first_seen":"2021-11-10","last_seen":"2024-07-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001683553","name":"SPRUCE BIOSCIENCES, INC.","url":"/issuer/0001683553","role":"Ten percent owner","n_filings":6,"first_seen":"2020-10-16","last_seen":"2024-03-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001785279","name":"Metagenomi, Inc.","url":"/issuer/0001785279","role":"Ten percent owner","n_filings":1,"first_seen":"2024-02-15","last_seen":"2024-02-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001662244","name":"Cyteir Therapeutics, Inc.","url":"/issuer/0001662244","role":"Ten percent owner","n_filings":9,"first_seen":"2021-06-23","last_seen":"2023-07-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001816736","name":"Disc Medicine, Inc.","url":"/issuer/0001816736","role":"Ten percent owner","n_filings":1,"first_seen":"2023-06-28","last_seen":"2023-06-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001637715","name":"Reneo Pharmaceuticals, Inc.","url":"/issuer/0001637715","role":"Ten percent owner","n_filings":2,"first_seen":"2021-04-14","last_seen":"2023-06-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001710072","name":"Edgewise Therapeutics, Inc.","url":"/issuer/0001710072","role":"Ten percent owner","n_filings":2,"first_seen":"2021-03-31","last_seen":"2022-09-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001641281","name":"Bolt Biotherapeutics, Inc.","url":"/issuer/0001641281","role":"Ten percent owner","n_filings":2,"first_seen":"2021-02-11","last_seen":"2022-07-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001651431","name":"Checkmate Pharmaceuticals, Inc.","url":"/issuer/0001651431","role":"Ten percent owner","n_filings":2,"first_seen":"2020-08-13","last_seen":"2022-02-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001786205","name":"Arcellx, Inc.","url":"/issuer/0001786205","role":"Ten percent owner","n_filings":1,"first_seen":"2022-02-09","last_seen":"2022-02-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001452965","name":"MINERVA SURGICAL INC","url":"/issuer/0001452965","role":"Ten percent owner","n_filings":1,"first_seen":"2021-10-27","last_seen":"2021-10-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001840574","name":"Verve Therapeutics, Inc.","url":"/issuer/0001840574","role":"Ten percent owner","n_filings":1,"first_seen":"2021-06-22","last_seen":"2021-06-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001294133","name":"Inogen Inc","url":"/issuer/0001294133","role":"Ten percent owner, Other","n_filings":4,"first_seen":"2014-02-24","last_seen":"2021-06-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001563577","name":"Galera Therapeutics, Inc.","url":"/issuer/0001563577","role":"Ten percent owner, Other","n_filings":3,"first_seen":"2019-11-14","last_seen":"2021-02-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001693011","name":"Inozyme Pharma, Inc.","url":"/issuer/0001693011","role":"Ten percent owner","n_filings":2,"first_seen":"2020-07-29","last_seen":"2021-02-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001800315","name":"Galecto, Inc.","url":"/issuer/0001800315","role":"Ten percent owner","n_filings":1,"first_seen":"2020-11-04","last_seen":"2020-11-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001719395","name":"Eargo, Inc.","url":"/issuer/0001719395","role":"Ten percent owner","n_filings":1,"first_seen":"2020-10-22","last_seen":"2020-10-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001799448","name":"Aligos Therapeutics, Inc.","url":"/issuer/0001799448","role":"Ten percent owner","n_filings":1,"first_seen":"2020-10-22","last_seen":"2020-10-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001802665","name":"Harmony Biosciences Holdings, Inc.","url":"/issuer/0001802665","role":"Ten percent owner","n_filings":1,"first_seen":"2020-08-25","last_seen":"2020-08-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001787400","name":"Nkarta, Inc.","url":"/issuer/0001787400","role":"Ten percent owner","n_filings":1,"first_seen":"2020-07-16","last_seen":"2020-07-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001626971","name":"Corvus Pharmaceuticals, Inc.","url":"/issuer/0001626971","role":"Ten percent owner","n_filings":6,"first_seen":"2016-03-30","last_seen":"2020-07-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001408443","name":"Milestone Pharmaceuticals Inc.","url":"/issuer/0001408443","role":"Ten percent owner, Other","n_filings":2,"first_seen":"2019-05-14","last_seen":"2019-11-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001759425","name":"Mirum Pharmaceuticals, Inc.","url":"/issuer/0001759425","role":"Ten percent owner","n_filings":1,"first_seen":"2019-07-23","last_seen":"2019-07-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001679363","name":"Morphic Holding, Inc.","url":"/issuer/0001679363","role":"Ten percent owner","n_filings":1,"first_seen":"2019-07-01","last_seen":"2019-07-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001724344","name":"Entasis Therapeutics Holdings Inc.","url":"/issuer/0001724344","role":"Ten percent owner","n_filings":1,"first_seen":"2018-10-01","last_seen":"2018-10-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001348911","name":"KalVista Pharmaceuticals, Inc.","url":"/issuer/0001348911","role":"Ten percent owner","n_filings":3,"first_seen":"2017-09-15","last_seen":"2017-10-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001169987","name":"HTG MOLECULAR DIAGNOSTICS, INC","url":"/issuer/0001169987","role":"Ten percent owner","n_filings":3,"first_seen":"2015-05-12","last_seen":"2017-08-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001370053","name":"ANAPTYSBIO INC","url":"/issuer/0001370053","role":"Ten percent owner","n_filings":5,"first_seen":"2017-02-01","last_seen":"2017-08-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001251769","name":"Apollo Endosurgery, Inc.","url":"/issuer/0001251769","role":"Ten percent owner","n_filings":2,"first_seen":"2017-05-11","last_seen":"2017-07-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001358762","name":"REATA PHARMACEUTICALS INC","url":"/issuer/0001358762","role":"Ten percent owner","n_filings":4,"first_seen":"2016-06-02","last_seen":"2017-06-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001410939","name":"Ophthotech Corp.","url":"/issuer/0001410939","role":"Ten percent owner, Other","n_filings":5,"first_seen":"2013-10-02","last_seen":"2016-12-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001481512","name":"Ra Pharmaceuticals, Inc.","url":"/issuer/0001481512","role":"Ten percent owner","n_filings":1,"first_seen":"2016-11-02","last_seen":"2016-11-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001388658","name":"iRhythm Technologies, Inc.","url":"/issuer/0001388658","role":"Ten percent owner","n_filings":1,"first_seen":"2016-10-26","last_seen":"2016-10-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001348649","name":"CoLucid Pharmaceuticals, Inc.","url":"/issuer/0001348649","role":"Ten percent owner","n_filings":2,"first_seen":"2015-05-12","last_seen":"2016-09-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001311596","name":"Tobira Therapeutics, Inc.","url":"/issuer/0001311596","role":"Ten percent owner","n_filings":7,"first_seen":"2015-05-06","last_seen":"2016-07-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001419600","name":"Flexion Therapeutics Inc","url":"/issuer/0001419600","role":"Ten percent owner, Other","n_filings":3,"first_seen":"2014-02-20","last_seen":"2015-06-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001444380","name":"NEVRO CORP","url":"/issuer/0001444380","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2014-11-13","last_seen":"2014-11-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001493566","name":"Otonomy, Inc.","url":"/issuer/0001493566","role":"Ten percent owner, Other","n_filings":2,"first_seen":"2014-08-19","last_seen":"2014-08-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001388325","retrieved_at":"2026-08-25T21:06:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}